08/19/2024 3:15 PM | Beam Therapeutics (Issuer) Cavanagh Bethany J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/06/2024 6:08 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 6:01 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 3:14 PM | Beam Therapeutics (Subject) Evans John M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 3:30 PM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 3:42 PM | Beam Therapeutics (Issuer) Fishman Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:42 PM | Beam Therapeutics (Issuer) Walsh Kathleen E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/07/2024 3:45 PM | Beam Therapeutics (Issuer) COOPER GRAHAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:47 PM | Beam Therapeutics (Issuer) Ho Carole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:47 PM | Beam Therapeutics (Issuer) MARAGANORE JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:48 PM | Beam Therapeutics (Issuer) Shaw Christi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 6:09 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:19 AM | Beam Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024 3:25 PM | Beam Therapeutics (Filer)
| Form ARS | |
04/19/2024 3:15 PM | Beam Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024 3:20 PM | Beam Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024 7:56 PM | Beam Therapeutics (Subject) Ciaramella Giuseppe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 7:57 PM | Beam Therapeutics (Subject) Burrell Terry-Ann (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 7:57 PM | Beam Therapeutics (Subject) Evans John M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 7:55 PM | Beam Therapeutics (Subject) Simon Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 7:56 PM | Beam Therapeutics (Subject) Bellon Christine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 6:39 PM | Beam Therapeutics (Issuer) Burrell Terry-Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:40 PM | Beam Therapeutics (Issuer) Bellon Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:43 PM | Beam Therapeutics (Issuer) Simon Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:33 PM | Beam Therapeutics (Issuer) Ciaramella Giuseppe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:36 PM | Beam Therapeutics (Issuer) Evans John M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:22 PM | Beam Therapeutics (Subject) Simon Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024 3:10 PM | Beam Therapeutics (Issuer) Simon Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:10 PM | Beam Therapeutics (Issuer) Burrell Terry-Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 5:13 PM | Beam Therapeutics (Subject) Evans John M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 6:40 AM | Beam Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 6:22 AM | Beam Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2024 5:43 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 1:34 PM | Beam Therapeutics (Issuer) FMR LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:18 PM | ARCH Venture Fund IX, L.P. (Filed by) Beam Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 2:38 PM | Beam Therapeutics (Subject) Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024 7:35 AM | Beam Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024 6:27 AM | Beam Therapeutics (Subject) Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/31/2024 3:47 PM | Beam Therapeutics (Subject) Evans John M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Beam Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024 3:59 PM | Beam Therapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
How the US Will Win the Great Lithium Race (Ad) China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill. Join GM as an early investor in this company by October 3. |
01/24/2024 7:42 AM | Beam Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/08/2024 5:55 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 3:30 PM | Beam Therapeutics (Issuer) Bellon Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 9:56 AM | Beam Therapeutics (Issuer) FMR LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:10 PM | Beam Therapeutics (Issuer) Shaw Christi (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/14/2023 3:15 PM | Beam Therapeutics (Issuer) Shaw Christi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:20 PM | Beam Therapeutics (Subject) Bellon Christine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 6:30 AM | Beam Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:00 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:30 PM | Beam Therapeutics (Issuer) Simon Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:44 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 3:41 PM | Beam Therapeutics (Subject) Simon Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 7:50 AM | Beam Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 3:30 PM | Beam Therapeutics (Issuer) Bellon Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 2:20 PM | Beam Therapeutics (Subject) Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |